全文获取类型
收费全文 | 28084篇 |
免费 | 2003篇 |
国内免费 | 57篇 |
专业分类
耳鼻咽喉 | 105篇 |
儿科学 | 759篇 |
妇产科学 | 801篇 |
基础医学 | 4332篇 |
口腔科学 | 139篇 |
临床医学 | 2491篇 |
内科学 | 7640篇 |
皮肤病学 | 278篇 |
神经病学 | 2166篇 |
特种医学 | 1098篇 |
外科学 | 4272篇 |
综合类 | 124篇 |
现状与发展 | 1篇 |
一般理论 | 45篇 |
预防医学 | 2177篇 |
眼科学 | 215篇 |
药学 | 1617篇 |
中国医学 | 16篇 |
肿瘤学 | 1868篇 |
出版年
2024年 | 16篇 |
2023年 | 733篇 |
2022年 | 1017篇 |
2021年 | 1314篇 |
2020年 | 1205篇 |
2019年 | 791篇 |
2018年 | 962篇 |
2017年 | 934篇 |
2016年 | 877篇 |
2015年 | 969篇 |
2014年 | 1660篇 |
2013年 | 1523篇 |
2012年 | 1415篇 |
2011年 | 1450篇 |
2010年 | 1344篇 |
2009年 | 1359篇 |
2008年 | 1267篇 |
2007年 | 1181篇 |
2006年 | 1045篇 |
2005年 | 1041篇 |
2004年 | 1083篇 |
2003年 | 1014篇 |
2002年 | 1016篇 |
2001年 | 1106篇 |
2000年 | 961篇 |
1999年 | 882篇 |
1998年 | 425篇 |
1997年 | 259篇 |
1996年 | 192篇 |
1995年 | 151篇 |
1994年 | 110篇 |
1993年 | 95篇 |
1992年 | 125篇 |
1991年 | 96篇 |
1990年 | 88篇 |
1989年 | 71篇 |
1988年 | 71篇 |
1987年 | 43篇 |
1985年 | 31篇 |
1984年 | 24篇 |
1983年 | 20篇 |
1982年 | 21篇 |
1981年 | 24篇 |
1980年 | 18篇 |
1979年 | 12篇 |
1978年 | 13篇 |
1977年 | 12篇 |
1975年 | 14篇 |
1974年 | 12篇 |
1973年 | 13篇 |
排序方式: 共有10000条查询结果,搜索用时 296 毫秒
71.
72.
73.
74.
75.
76.
77.
《Vaccine》2020,38(32):4940-4943
To determine the duration of immunity provided by the Hepatitis A vaccination (HepA), we evaluated a cohort of participants in Alaska 20 years after being immunized as infants. At recruitment, participants received two doses of inactivated HepA vaccine on one of three schedules. We conducted hepatitis A antibody (anti-HAV) testing for participants at the 20-year time-point. Seventy-five of the original 183 participants (41%) were available for follow-up. The overall anti-HAV geometric mean concentration was 29.9 mIU/mL (95% CI 22.4 mIU/mL, 39.7 mIU/mL) and 50 participants (68%) remained seropositive (titer ≥ 20 mIU/mL). Using a fractional polynomial model, the predicted percent seropositive at 25 years was 55.3%, 49.8% at 30 years and 45.7% at 35 years, suggesting that the percent sero-positive could drop below 50% earlier than previously expected. Further research is necessary to understand if protection continues after seropositivity diminishes or if a HepA booster dose may become necessary. 相似文献
78.
《Vaccine》2016,34(41):5034-5039
BackgroundAs the World Health Organization (WHO) currently recommends that children be protected against 11 different pathogens, it is becoming increasingly necessary to administer multiple injectable vaccines during a single immunization visit. In this study we assess Gambian healthcare providers’ and infant caregivers’ attitudes and practices related to the administration of multiple injectable vaccines to a child at a single immunization visit before and after the 2015 introduction of inactivated polio vaccine (IPV). IPV introduction increased the number of injectable vaccines recommended for the 4-month immunization visit from two to three in The Gambia.MethodsWe conducted a cross-sectional questionnaire-based survey before and after the introduction of IPV at 4 months of age in a representative sample of all health facilities providing immunizations in The Gambia. Healthcare providers who administer vaccines at the selected health facilities and caregivers who brought infants for their 4 month immunization visit were surveyed.FindingsPrior to IPV introduction, 9.9% of healthcare providers and 35.7% of infant caregivers expressed concern about a child receiving more than 2 injections in a single visit. Nevertheless, 98.8% and 90.9% of infants received all required vaccinations for the visit before and after IPV introduction, respectively. The only reason why vaccines were not received was vaccine stock-outs. Infant caregivers generally agreed that vaccinators could be trusted to provide accurate information regarding the number of vaccines that a child needed.ConclusionHealthcare providers and infant caregivers in this resource limited setting accepted an increase in the number of injectable vaccines administered at a single visit even though some expressed concerns about the increase. 相似文献
79.
Exercise induced dyspnoea (EID) is a common manifestation in children and adolescents. Although EID is commonly attributed to exercise induced bronchoconstriction, several conditions other than asthma can cause EID in otherwise healthy children and adolescents. Cardiopulmonary exercise testing (CPET) offers a non-invasive comprehensive assessment of the cardiovascular, ventilatory and metabolic responses to exercise and is a powerful diagnostic and prognostic tool. CPET is a reproducible, non-invasive form of testing that allows for comparison against age- and gender-specific norms. CPET can assess the child’s exercise capacity, determine the limiting factors associated with this, and be used to prescribe individualised interventions. EID can occur due to asthma, exercise induced laryngeal obstruction, breathing pattern disorders, chest wall restriction and cardiovascular pathology among other causes. Differentiating between these varied causes is important if effective therapy is to be initiated and quality of life improved in subjects with EID. 相似文献
80.
Julie A. Schmidt Georgina K. Fensom Sabina Rinaldi Augustin Scalbert Paul N. Appleby David Achaintre Audrey Gicquiau Marc J. Gunter Pietro Ferrari Rudolf Kaaks Tilman Kühn Heiner Boeing Antonia Trichopoulou Anna Karakatsani Eleni Peppa Domenico Palli Sabina Sieri Rosario Tumino Bas Bueno-de-Mesquita Antonio Agudo Maria-Jose Sánchez María-Dolores Chirlaque Eva Ardanaz Nerea Larrañaga Aurora Perez-Cornago Nada Assi Elio Riboli Konstantinos K. Tsilidis Timothy J. Key Ruth C. Travis 《International journal of cancer. Journal international du cancer》2020,146(3):720-730
Metabolomics may reveal novel insights into the etiology of prostate cancer, for which few risk factors are established. We investigated the association between patterns in baseline plasma metabolite profile and subsequent prostate cancer risk, using data from 3,057 matched case–control sets from the European Prospective Investigation into Cancer and Nutrition (EPIC). We measured 119 metabolite concentrations in plasma samples, collected on average 9.4 years before diagnosis, by mass spectrometry (AbsoluteIDQ p180 Kit, Biocrates Life Sciences AG). Metabolite patterns were identified using treelet transform, a statistical method for identification of groups of correlated metabolites. Associations of metabolite patterns with prostate cancer risk (OR1SD) were estimated by conditional logistic regression. Supplementary analyses were conducted for metabolite patterns derived using principal component analysis and for individual metabolites. Men with metabolite profiles characterized by higher concentrations of either phosphatidylcholines or hydroxysphingomyelins (OR1SD = 0.77, 95% confidence interval 0.66–0.89), acylcarnitines C18:1 and C18:2, glutamate, ornithine and taurine (OR1SD = 0.72, 0.57–0.90), or lysophosphatidylcholines (OR1SD = 0.81, 0.69–0.95) had lower risk of advanced stage prostate cancer at diagnosis, with no evidence of heterogeneity by follow-up time. Similar associations were observed for the two former patterns with aggressive disease risk (the more aggressive subset of advanced stage), while the latter pattern was inversely related to risk of prostate cancer death (OR1SD = 0.77, 0.61–0.96). No associations were observed for prostate cancer overall or less aggressive tumor subtypes. In conclusion, metabolite patterns may be related to lower risk of more aggressive prostate tumors and prostate cancer death, and might be relevant to etiology of advanced stage prostate cancer. 相似文献